Impact of the generation of EGFR‐TKIs administered as prior therapy on the efficacy of osimertinib in patients with non‐small cell lung cancer harboring EGFR T790M mutation

Abstract Background There are few studies that directly compare the effects of osimertinib on patients with non‐small cell lung cancer (NSCLC) harboring epidermal growth factor receptor (EGFR) T790M mutation between the generation of prior EGFR tyrosine kinase inhibitors (TKIs). Methods We retrospec...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Yosuke Miyashita, Ryo Ko, Naoko Shimada, Yoichiro Mitsuishi, Keita Miura, Naohisa Matsumoto, Tetsuhiko Asao, Takehito Shukuya, Rina Shibayama, Ryo Koyama, Kazuhisa Takahashi
Formato:	Artigo
Idioma:	Inglês
Publicado em:	Wiley 2021-02-01
coleção:	Thoracic Cancer
Assuntos:	EGFR mutation EGFR‐TKI non‐small cell lung cancer
Acesso em linha:	https://doi.org/10.1111/1759-7714.13742
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!